$858 Million is the total value of Crestline Management, LP's 143 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACA | ARCOSA INC | $14,651,998 | -5.1% | 203,783 | 0.0% | 1.71% | +5.9% | |
| SANA | SANA BIOTECHNOLOGY INC | $13,024,965 | -35.1% | 3,365,624 | 0.0% | 1.52% | -27.6% | |
| GPRE | GREEN PLAINS INC | $6,984,374 | -6.6% | 232,039 | 0.0% | 0.81% | +4.2% | |
| GXO LOGISTICS INCORPORATED | $6,480,473 | -6.6% | 110,494 | 0.0% | 0.76% | +4.1% | ||
| VCSH | VANGUARD SCOTTSDALE FDSshrt trm corp bd | $3,863,988 | -0.7% | 51,417 | 0.0% | 0.45% | +10.8% | |
| FLR | FLUOR CORP NEW | $2,943,377 | +24.0% | 80,201 | 0.0% | 0.34% | +38.3% | |
| KKR | KKR & CO INC | $2,772,000 | +10.0% | 45,000 | 0.0% | 0.32% | +22.8% | |
| EGHT | 8X8 INC NEW | $2,515,918 | -40.4% | 998,380 | 0.0% | 0.29% | -33.6% | |
| KBR | KBR INC | $2,426,442 | -9.4% | 41,168 | 0.0% | 0.28% | +1.1% | |
| BERY | BERRY GLOBAL GROUP INC | $2,041,111 | -3.8% | 32,969 | 0.0% | 0.24% | +7.2% | |
| SLQD | ISHARES TR0-5yr invt gr cp | $1,248,000 | -0.4% | 26,000 | 0.0% | 0.14% | +10.7% | |
| VERA | VERA THERAPEUTICS INCcl a | $622,160 | -14.6% | 45,380 | 0.0% | 0.07% | -5.3% | |
| TVTX | TRAVERE THERAPEUTICS INC | $549,104 | -41.8% | 61,421 | 0.0% | 0.06% | -35.4% | |
| PBYI | PUMA BIOTECHNOLOGY INC | $85,841 | -25.5% | 32,639 | 0.0% | 0.01% | -16.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DENALI THERAPEUTICS INC | 24 | Q3 2023 | 98.0% |
| MICROCHIP TECHNOLOGY INC. | 20 | Q3 2023 | 1.0% |
| META PLATFORMS INC | 16 | Q3 2023 | 3.8% |
| ANALOG DEVICES INC | 16 | Q3 2023 | 1.8% |
| VOYA FINL INC | 15 | Q2 2023 | 1.3% |
| AMERICAN INTL GROUP INC | 14 | Q3 2023 | 1.6% |
| MICROSOFT CORP | 14 | Q3 2023 | 2.0% |
| GRAPHIC PACKAGING HLDG CO | 14 | Q3 2023 | 0.9% |
| JUNO THERAPEUTICS INC | 13 | Q4 2017 | 100.0% |
| ALLSTATE CORP | 13 | Q3 2023 | 1.9% |
View Crestline Management, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 4 | 2022-06-16 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Crestline Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.